Hypertension after renal transplantation and polymorphism of genes involved in essential hypertension: ACE, AGT, AT1R and ecNOS

Clinical Nephrology

Volumn 57, Issue 3, 2002, Pages 192-200

  El Essawy, A Basset ^a   Berthoux, P ^a   Cecillon S ^a   Deprele C ^a   Thibaudin, D ^a   De Filippis, J P ^a   Alamartine, E ^a   Berthoux, F ^a  

^a HÔPITAL NORD   (France)

Author keywords

Angiotensin I converting enzyme; Angiotensin II type 1 receptor; Angiotensinogen; Arterial hypertension; Cyclosporine A; Endothelial consecutive nitric oxide synthase; gene polymorphism; Renal transplantation

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSINOGEN; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DNA; IMMUNOSUPPRESSIVE AGENT; NITRIC OXIDE SYNTHASE; PREDNISONE; SODIUM; SODIUM CHLORIDE; WATER;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CADAVER KIDNEY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CONTROL; DISEASE SEVERITY; DNA POLYMORPHISM; ENDOTHELIUM; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FEMALE; GENE FUNCTION; GENOTYPE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRESCRIPTION; PREVALENCE; RECIPIENT; RETROSPECTIVE STUDY; SCHOOL CHILD; SODIUM RETENTION; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; WATER RETENTION;

EID: 0036195478     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP57192     Document Type: Article

References (41)

1. Nitric oxide in the pathogenesis of hypertension
2. Correlation between angiotensin-converting enzyme gene insertion/deletion polymorphism and kidney graft long-term outcome in pediatric patients
3. Angiotensin-converting enzyme insertion/deletion genotype and long-term renal allograft survival
4. Angiotensin-converting enzyme genotype and renal allograft survival
5. Polymorphism study in primary IgA nephritis (IgAN) of genes (ACE, AGT, AT1-R, eNOS) involved in arterial hypertension
6. Angiotensin II type 1 receptor gene polymorphism in human essential hypertension
7. Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension
8. Risk factors for long-term renal survival after renal transplantation: A role for angiotensin-converting enzyme (insertion/deletion) polymorphism?
9. Hypertension in patients after renal transplantation
10. ecNOS overexpression in CsA-treated renal transplant patients: Implications for CsA-induced hypertension
11. Linkage of the angiotensinogen gene to essential hypertension
12. Hypertension induced by drugs and other substances
13. Cyclosporin in therapeutic doses increases renal allograft vascular resistance
14. ACE gene typing
15. Blockade of endothelium-dependent responses in conscious rats by cyclosporin A: Effect of L-arginine
16. A simple molecular assay for the C1166 variant of the angiotensin II type 1 receptor gene
17. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population
18. M235T variant of the human angiotensinogen gene in unselected hypertensive patients
19. Molecular basis of human hypertension: Role of angiotensinogen
20. Angiotensin I-converting enzyme insertion/deletion polymorphism: Potential significance in nephrology
21. Regulation of endothelial NO synthase expression by cyclosporin A in bovine aortic endothelial cells
22. Hypertension in renal transplant recipients
23. Pathophysiology and treatment of post-transplant hypertension
24. Mechanism of cyclosporine-induced hypertension
25. Incidence of posttransplant hypertension among renal allograft recipients
26. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene
27. Angiotensin II type 1 receptor gene polymorphism predicts the response to losartan and angiotensin II
28. The association of chronic kidney graft failure with recipient blood pressure
29. An insertion/deletion polymorphism in the angiotensin I-converting enzyme accounting for half the variance of serum enzyme levels
30. PCR detection of the insertion/deletion polymorphism of the human angiotensin-converting enzyme peptidase 1
31. Vascular mechanisms of cyclosporin-induced hypertension in the rat
32. Mutagenically separated PCR (MS-PCR): A highly specific one-step procedure for easy mutation detection
33. Purification of nucleic acides - Extraction with phenol: Chloroform
34. Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset
35. Association of ACE gene polymorphism and diabetic nephropathy?
36. No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis
37. Cyclosporin A increases nitric oxyde activity in vivo
38. Evidence of association of ecNOS gene polymorphism with plasma NO metabolite levels in humans
39. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene
40. Role of the deletion polymorphism of the angiotensin-converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy
41. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension